Charlotte's Web Holdings CWBHF
OTC CWBHF
$0.31 +0.02 (+6.21%)
At close: Aug 19, 2026 · 2:50 PM UTC

Charlotte's Web Holdings (CWBHF) Income towards Parent Company (2021 - 2026)

Charlotte's Web Holdings (CWBHF) posted quarterly Income towards Parent Company of -$13.1 million for Q1 2026, down 111.08% year-over-year from $118.4 million in Q1 2025, and down 14.79% quarter-over-quarter from -$11.4 million in Q4 2025.

Charlotte's Web Holdings (CWBHF) Income towards Parent Company (2021 - 2026) Analysis & Trends

Charlotte's Web Holdings (CWBHF) has reported Income towards Parent Company for 6 consecutive years, with -$13.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Income towards Parent Company fell 111.08% year-over-year to -$13.1 million; the TTM figure through Mar 2026 stood at -$36.6 million (down 38.67% YoY), while the FY2025 annual figure was -$29.7 million, changed 0.35% from the prior year.
  • Income towards Parent Company eased to -$13.1 million in Q1 2026 per CWBHF's latest filing, from -$11.4 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $2.8 million in Q2 2023 and bottomed at -$35.2 million in Q4 2022.
  • Historically, Income towards Parent Company has averaged -$9.2 million across 5 years, with a median of -$7.9 million in 2022.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company sank 876.58% — and 2023, when it surged 136.14%.
  • Charlotte's Web Holdings' Income towards Parent Company stood at -$35.2 million in 2022, then surged by 75.63% to -$8.6 million in 2023, then jumped by 60.77% to -$3.4 million in 2024, then plunged by 239.16% to -$11.4 million in 2025, then decreased by 14.79% to -$13.1 million in 2026.
  • Business Quant data shows CWBHF's Income towards Parent Company at -$13.1 million in Q1 2026, -$11.4 million in Q4 2025, and -$5.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.87 Bn 42.91 Bn -
2 Teva Pharmaceutical Industries 43.00 Bn 39.35 Bn 2.15 Bn
3 Zoetis 31.59 Bn 29.92 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn
7 Neurocrine Biosciences 15.55 Bn 15.16 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn -
10 Charlotte's Web Holdings 63.58 Mn 49.59 Mn 5.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.13 Mn
Mar 31, 2026 -13.11 Mn
Dec 31, 2025 -11.42 Mn
Sep 30, 2025 -5.82 Mn
Jun 30, 2025 -6.29 Mn
Mar 31, 2025 -6.21 Mn
Dec 31, 2024 -3.37 Mn
Sep 30, 2024 -5.79 Mn
Jun 30, 2024 -11.06 Mn
Mar 31, 2024 -9.63 Mn
Dec 31, 2023 -8.59 Mn
Sep 30, 2023 -15.14 Mn
Jun 30, 2023 2.84 Mn
Mar 31, 2023 -2.91 Mn
Dec 31, 2022 -35.23 Mn
Sep 30, 2022 -7.59 Mn
Jun 30, 2022 -7.87 Mn
Mar 31, 2022 -8.63 Mn
Dec 31, 2021 -118.25 Mn
Sep 30, 2021 -777,000.00